1. Home
  2. CPHI vs XBIO Comparison

CPHI vs XBIO Comparison

Compare CPHI & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPHI
  • XBIO
  • Stock Information
  • Founded
  • CPHI N/A
  • XBIO N/A
  • Country
  • CPHI China
  • XBIO United States
  • Employees
  • CPHI N/A
  • XBIO N/A
  • Industry
  • CPHI Biotechnology: Pharmaceutical Preparations
  • XBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPHI Health Care
  • XBIO Health Care
  • Exchange
  • CPHI Nasdaq
  • XBIO Nasdaq
  • Market Cap
  • CPHI 5.3M
  • XBIO 5.9M
  • IPO Year
  • CPHI N/A
  • XBIO N/A
  • Fundamental
  • Price
  • CPHI $1.56
  • XBIO $2.48
  • Analyst Decision
  • CPHI
  • XBIO Hold
  • Analyst Count
  • CPHI 0
  • XBIO 1
  • Target Price
  • CPHI N/A
  • XBIO N/A
  • AVG Volume (30 Days)
  • CPHI 8.8K
  • XBIO 74.4K
  • Earning Date
  • CPHI 11-12-2025
  • XBIO 11-13-2025
  • Dividend Yield
  • CPHI N/A
  • XBIO N/A
  • EPS Growth
  • CPHI N/A
  • XBIO N/A
  • EPS
  • CPHI N/A
  • XBIO N/A
  • Revenue
  • CPHI $4,052,266.00
  • XBIO $2,858,935.00
  • Revenue This Year
  • CPHI N/A
  • XBIO $1.99
  • Revenue Next Year
  • CPHI N/A
  • XBIO $20.00
  • P/E Ratio
  • CPHI N/A
  • XBIO N/A
  • Revenue Growth
  • CPHI N/A
  • XBIO 13.30
  • 52 Week Low
  • CPHI $1.20
  • XBIO $2.20
  • 52 Week High
  • CPHI $3.35
  • XBIO $13.93
  • Technical
  • Relative Strength Index (RSI)
  • CPHI 41.82
  • XBIO 37.99
  • Support Level
  • CPHI $1.46
  • XBIO $2.29
  • Resistance Level
  • CPHI $1.61
  • XBIO $2.72
  • Average True Range (ATR)
  • CPHI 0.07
  • XBIO 0.20
  • MACD
  • CPHI 0.01
  • XBIO 0.00
  • Stochastic Oscillator
  • CPHI 52.41
  • XBIO 26.46

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: